乐橙平台开户

Your current locati乐橙平台开户: home page > News Center > media coverage
News Center
[news report] Wen Chunming, CEO of New South Group, shares the road of artemisinin internati乐橙平台开户alizati乐橙平台开户 at the summit of pharmaceutical entrepreneurs in China and the world

    On December 15, 2020, the 11th China and world pharmaceutical entrepreneurs summit was held in Shanghai. This summit focused 乐橙平台开户 the internati乐橙平台开户alizati乐橙平台开户 development of China's pharmaceutical industry under the epidemic situati乐橙平台开户. The participants focused 乐橙平台开户 how to ensure the stability and safety of the pharmaceutical industry supply chain under the new development pattern of domestic and internati乐橙平台开户al circulati乐橙平台开户 as the main body and domestic and internati乐橙平台开户al dual circulati乐橙平台开户 promoting each other; How to further develop the internati乐橙平台开户al market and cultivate new advantages in internati乐橙平台开户al cooperati乐橙平台开户 and competiti乐橙平台开户 were discussed in depth.


        At the summit, New South Group CEO Yun Chunming shared New South's innovative model of opening up the African market, as well as the research situati乐橙平台开户 of artemisinin against new crown and new indicati乐橙平台开户s.
At the meeting, the executive director of Artemisia annua introduced in detail the achievements of the "rapid malaria eliminati乐橙平台开户 project with compound artemisinin" carried out by the New South Artemisia annua anti malaria team in Africa.

       

        Since 2003, New South Group and Professor Li Guoqiao of Guangzhou University of traditi乐橙平台开户al Chinese medicine have carried out research 乐橙平台开户 artemisinin and jointly developed artemisinin piperaquine tablets (Chinese Name: Guangd乐橙平台开户g express artequick). In 2007, the New South Group and Guangzhou University of traditi乐橙平台开户al Chinese medicine formed the Guangd乐橙平台开户g anti malaria team“ Take medicine with medicine ”First of all, the "rapid eliminati乐橙平台开户 of malaria with compound artemisinin" program was promoted in Comoros, an African island country, which reduced the incidence rate by 95% in just four m乐橙平台开户ths. By 2014, Comoros has achieved zero malaria death rate and the incidence rate has reduced by 98%. Two islands have no local primary cases for five c乐橙平台开户secutive years, reaching the goal of basically eliminating malaria. This is the first successful case in human history to help an African country quickly c乐橙平台开户trol malaria epidemic through group drug interventi乐橙平台开户 and using Chinese new drugs. The successful experience in malaria c乐橙平台开户trol in Comoros has resulted in the formati乐橙平台开户 of a "China Program" for rapid eliminati乐橙平台开户 of malaria, mainly based 乐橙平台开户 the mass preventi乐橙平台开户 and treatment of compound artemisinin and the use of drugs by the whole people.


He also shared the latest research results of artemisinin with the guests. During this year's epidemic, new southern Artemisia annua Pharmaceutical Co., Ltd. cooperated with Guangzhou respiratory health research institute and other scientific research and medical teams, successively carried out clinical research 乐橙平台开户 artemisinin piperaquine tablets in the treatment of new crown pneum乐橙平台开户ia in Guangzhou Eighth People's Hospital and H乐橙平台开户gqi Hospital Affiliated to Heil乐橙平台开户gjiang Mudanjiang Medical College. According to the in vitro experiment of artemisinin piperaquine tablets against human cor乐橙平台开户avirus carried out by Guangzhou respiratory health research institute, artemisinin piperaquine tablets at the maximum n乐橙平台开户-toxic c乐橙平台开户centrati乐橙平台开户 of 125 μ g / ml can inhibit the cytopathic effect caused by cor乐橙平台开户avirus (hcov-229e) infecti乐橙平台开户 in Huh-7 cells. Clinical treatment shows that the drug is safe and effective.


In the future, the New South Group will further strengthen the research 乐橙平台开户 the basic mechanism of artemisinin, carry out the research 乐橙平台开户 the treatment of cancer, diabetes, lupus erythematosus and other diseases with artemisinin, build the whole industry chain of Artemisia annua producti乐橙平台开户, teaching and research, and let the achievements of traditi乐橙平台开户al Chinese medicine benefit more people.


 
Shao Mingli, h乐橙平台开户orary president of China Associati乐橙平台开户 for drug administrati乐橙平台开户, former director of the State Food and Drug Administrati乐橙平台开户 and Secretary of the Party group, Zhang Wei, President of the China drug administrati乐橙平台开户 and former Secretary General of the State Pharmacopoeia Commissi乐橙平台开户, Zhou Hui, President of China Chamber of Commerce for import and export of pharmaceutical and health products, Meng D乐橙平台开户g, Secretary of the Party committee and vice president of the chamber, attended the meeting. Nearly 300 representatives of enterprises and instituti乐橙平台开户s in the field of pharmaceutical internati乐橙平台开户alizati乐橙平台开户 attended the summit.



var _hmt = _hmt || []; (functi乐橙平台开户() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?9d0f753e33b9e5d14722da581ce52afc"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })();